Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits

Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).

Toichi Takenaka, Shinji Usuda, Takao Nomura et al. · PubMed · 1976 · 87 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.

Kiyoshi Oizumi, Hiroshi Nishino, Hiroyuki Koike et al. · The Japanese Journal of Pharmacology · 1989 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.

Yuichi Masuda, Midori Takeguchi, Chizuru Arakawa et al. · PubMed · 1990 · 41 citations

Medicine, Cardiology, Pharmacology +12

Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs.

Sakuya Tanaka, Yutaka Kasuya, Yukinori Masuda et al. · Journal of Pharmacobio-Dynamics · 1983 · 40 citations · Full text

Medicine, Cardiology, Pharmacology +13

Opposite central cardiovascular effects of nifedipine and BAY k 8644 in anesthetized rats.

Stéphane Laurent, X. Girerd, D Tsoukaris-Kupfer et al. · Hypertension · 1987 · 40 citations · Full text

Medicine, Pharmacology, Physiology +17